{"id":279593,"date":"2022-11-13T13:36:05","date_gmt":"2022-11-13T19:36:05","guid":{"rendered":"https:\/\/www.liveaction.org\/news\/?p=279593"},"modified":"2022-11-11T13:41:41","modified_gmt":"2022-11-11T19:41:41","slug":"fda-considers-first-counter-birth-control-pill","status":"publish","type":"post","link":"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/","title":{"rendered":"FDA considers approval of first over-the-counter birth control pill"},"content":{"rendered":"
<\/div>

This month, the U.S. Food and Drug Administration (FDA) is reviewing an application for over-the-counter birth control<\/a>. While more than 20 states have already approved dispensation of hormonal birth control without a doctor\u2019s office visit, each state still requires that a licensed pharmacist dispense the medication after<\/span><\/i> reviewing a medical history questionnaire filled out by the patient. <\/span><\/p>\n

But if the FDA approves French pharmaceutical company HRA Pharma\u2019s \u201cO-pill\u201d progestin-only birth control, it will be available truly over-the-counter just like Tylenol or Motrin \u2014\u00a0without any doctor, physician assistant, nurse practitioner <\/span>or<\/span><\/i> pharmacist contact.\u00a0<\/span><\/p>\n

URGENT:\u00a0<\/b>For every dollar given, 34 more people can be reached with the truth about abortion. Will you join us in this life-saving work as a monthly donor today?<\/i><\/b><\/a><\/p>\n

Advocates claim progestin-only contraception safer than the Pill<\/strong><\/h3>\n

While <\/span>21 states Attorneys General<\/span><\/a> as well as the <\/span>American College of Obstetricians and Gynecologists (ACOG) <\/span><\/a>are pushing for FDA approval of OTC birth control (and in ACOG\u2019s case has been pushing for it since 2019) in order to \u201cincrease access\u201d to contraception, their full-throated advocacy unfortunately downplays or even ignores important safety considerations. <\/span><\/p>\n

Progestin-only birth control like O-pill is commonly assumed to be safer than the Pill because it doesn\u2019t contain estrogen, which is associated with an increased risk of serious or even <\/span>fatal blood clots<\/span><\/a>. But that doesn\u2019t make O-pill or progestin-only birth control harmless and innocuous like the states Attorneys General appear to believe when they parrot the Centers for Disease Control and Prevention\u2019s (CDC) claim that \u201c[n]o examinations or tests are needed before starting progestin-only pills.\u201d The AGs fail to note that the <\/span>CDC document<\/span><\/a> was last reviewed in 2017, before any formal advocacy for over-the-counter birth control was even on the table.\u00a0<\/span><\/p>\n

According to an<\/span> Associated Press article<\/span><\/a>, HRA Pharma cited seven years of safety studies as proof of O-pill\u2019s appropriateness for OTC use, but while many women take <\/span>hormonal birth control for years<\/span><\/a>, even decades on and off, the company\u2019s largest study followed 1,000 women for just six months<\/em>. Some of the research was funded in part by the contraception advocacy organization <\/span>Oral Contraceptives Over-the-Counter Working Group, according to the Associated Press.\u00a0<\/span><\/p>\n

Side effects of progestin-only contraception<\/strong><\/h3>\n

Research suggests that women who take progestin-only birth control are at increased risk of developing <\/span>breast cancer<\/span><\/a>, <\/span>cervical cancer<\/span><\/a>, and brain cancer, and a 2015 <\/span>study<\/span><\/a> found that glioma risk nearly tripled for women taking progestin-only birth control when compared to women who had never taken hormonal contraception.\u00a0<\/span><\/p>\n

Furthermore, while ectopic pregnancy occurs in 2-5% of pregnancies in the general population, <\/span>10% of women who conceived<\/span><\/a> while taking progestin-only contraception experienced ectopic pregnancies. Besides ectopic pregnancy, the O-pill <\/span>product label<\/span><\/a> also contains warnings about ovarian cysts, irregular bleeding (reported by <\/span>nearly half<\/span><\/i> of women in HRA Pharma\u2019s clinical trials, and cited as the primary reason for stopping the drug by \u2154 of the 17.4% of studied women who discontinued the medication for side effects), and liver disease.\u00a0<\/span><\/p>\n

Other <\/span>common side effects<\/span><\/a> in research studies included \u201cHeadache, Dizziness, Nausea, Increased appetite, Abdominal pain, cramps and bloating, Fatigue, Vaginal discharge,<\/span> Dysmenorrhea (painful periods), Nervousness, Backache, Breast discomfort, Acne.\u201d\u00a0<\/span><\/p>\n

Progestin-only hormonal birth control, like the Pill, is <\/span>also known to increase depression risk<\/span><\/a>, especially in young women.\u00a0<\/span><\/p>\n

Other issues with OTC birth control<\/strong><\/h3>\n

OTC contraception access could have negative repercussions for the already high rates of multiple sexually transmitted infections (STIs), since STIs are often diagnosed during contraception office visits. Healthcare providers (repeating the claims of mainstream medical organizations like ACOG) already often downplay the significant risks associated with hormonal contraceptive use. Making hormonal birth control OTC is likely to give users a false sense of security and safety.\u00a0<\/span><\/p>\n

O-pill has the potential to be abortifacient<\/strong><\/h3>\n

While the Pill works primarily by stopping ovulation, O-pill functions differently, preventing ovulation in only about half<\/em> of users\u2019 cycles, according to<\/span> Rxlist.com<\/span><\/a>. Its consistent mechanisms of action include \u201cthickening the cervical mucus to inhibit sperm penetration, lowering the midcycle LH and FSH peaks, slowing the movement of the ovum through the fallopian tubes, and altering the endometrium,\u201d according to the<\/span> product label<\/span><\/a>. In other words, breakthrough ovulation is not only possible but expected to occur in about half of cycles. If sperm does get through the thickened cervical mucus and conception occurs, O-pill\u2019s backup mechanism of action, thinning the uterine lining (the endometrium) would make the pill <\/span>abortifacient<\/span><\/a>, preventing a newly created blastocyst from<\/span> implanting in the uterine wall<\/span><\/a>.\u00a0<\/span><\/p>\n

Contraception is inextricably linked to abortion<\/strong><\/h3>\n

While abortion advocates routinely insist that <\/span>contraceptive access is the linchpin for decreasing abortion rates<\/span><\/a>, the reality is that contraception and abortion are inextricably linked. A former Planned Parenthood manager <\/span>called them<\/span><\/a> \u201ctwo sides of the same coin.\u201d Tellingly, the AP article <\/span>acknowledged<\/span><\/a> that advocates for OTC contraception see this as a necessary step towards OTC abortion.\u00a0<\/span><\/p>\n

The FDA\u2019s decision is expected in the first part of 2023. <\/span><\/p>\n

\"\"<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

This month, the U.S. Food and Drug Administration (FDA) is reviewing an application for over-the-counter birth control. While more than 20 states have already approved dispensation of hormonal birth control without a doctor\u2019s office visit, each state still requires that a licensed pharmacist dispense the medication after reviewing a medical history questionnaire filled out by […]<\/p>\n","protected":false},"author":635,"featured_media":279621,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false},"categories":[15,3473],"tags":[],"yoast_head":"\nFDA considers approval of first over-the-counter birth control pill<\/title>\n<meta name=\"description\" content=\"HRA Pharma cited 7 years of safety studies as proof of O-pill\u2019s appropriateness for OTC use, but its largest study followed 1,000 women for just 6 months.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA considers approval of first over-the-counter birth control pill\" \/>\n<meta property=\"og:description\" content=\"HRA Pharma cited 7 years of safety studies as proof of O-pill\u2019s appropriateness for OTC use, but its largest study followed 1,000 women for just 6 months.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/\" \/>\n<meta property=\"og:site_name\" content=\"Live Action News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/liveaction\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-13T19:36:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-11T19:41:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/11\/GettyImages-1241745725-birth-control.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"581\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Anne Marie Williams, RN, BSN\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@liveaction\" \/>\n<meta name=\"twitter:site\" content=\"@liveaction\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anne Marie Williams, RN, BSN\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/\"},\"author\":{\"name\":\"Anne Marie Williams, RN, BSN\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/48e3f680e24f898411f4ea650018e01b\"},\"headline\":\"FDA considers approval of first over-the-counter birth control pill\",\"datePublished\":\"2022-11-13T19:36:05+00:00\",\"dateModified\":\"2022-11-11T19:41:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/\"},\"wordCount\":821,\"publisher\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\"},\"articleSection\":[\"Analysis\",\"Newsbreak\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/\",\"url\":\"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/\",\"name\":\"FDA considers approval of first over-the-counter birth control pill\",\"isPartOf\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#website\"},\"datePublished\":\"2022-11-13T19:36:05+00:00\",\"dateModified\":\"2022-11-11T19:41:41+00:00\",\"description\":\"HRA Pharma cited 7 years of safety studies as proof of O-pill\u2019s appropriateness for OTC use, but its largest study followed 1,000 women for just 6 months.\",\"breadcrumb\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/archive.liveaction.org\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA considers approval of first over-the-counter birth control pill\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#website\",\"url\":\"https:\/\/archive.liveaction.org\/news\/\",\"name\":\"Live Action News\",\"description\":\"Covering Human Rights, Abortion, & Pro-Life Issues\",\"publisher\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/archive.liveaction.org\/news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#organization\",\"name\":\"Live Action\",\"url\":\"https:\/\/archive.liveaction.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png\",\"contentUrl\":\"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png\",\"width\":701,\"height\":710,\"caption\":\"Live Action\"},\"image\":{\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/liveaction\",\"https:\/\/twitter.com\/liveaction\",\"https:\/\/www.instagram.com\/liveactionorg\/\",\"https:\/\/www.pinterest.com\/LiveActionFilms\/\",\"https:\/\/www.youtube.com\/user\/LiveActionFilms\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/48e3f680e24f898411f4ea650018e01b\",\"name\":\"Anne Marie Williams, RN, BSN\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/27753e50a006dd85ec60e2a77e6c6a52?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/27753e50a006dd85ec60e2a77e6c6a52?s=96&d=mm&r=g\",\"caption\":\"Anne Marie Williams, RN, BSN\"},\"description\":\"Anne Marie Williams is a mom of five with 10 years of nursing experience, primarily in the ICU setting. Her writing advocates for an approach to women's health that respects and supports the female body and fertility, and educates on the harms of hormonal birth control. She hosts a postpartum podcast to help other moms experience postpartum as a time of grit, growth, and grace.\",\"url\":\"https:\/\/archive.liveaction.org\/news\/author\/anne-marie-williams\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA considers approval of first over-the-counter birth control pill","description":"HRA Pharma cited 7 years of safety studies as proof of O-pill\u2019s appropriateness for OTC use, but its largest study followed 1,000 women for just 6 months.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/","og_locale":"en_US","og_type":"article","og_title":"FDA considers approval of first over-the-counter birth control pill","og_description":"HRA Pharma cited 7 years of safety studies as proof of O-pill\u2019s appropriateness for OTC use, but its largest study followed 1,000 women for just 6 months.","og_url":"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/","og_site_name":"Live Action News","article_publisher":"https:\/\/www.facebook.com\/liveaction","article_published_time":"2022-11-13T19:36:05+00:00","article_modified_time":"2022-11-11T19:41:41+00:00","og_image":[{"width":1200,"height":581,"url":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2022\/11\/GettyImages-1241745725-birth-control.jpg","type":"image\/jpeg"}],"author":"Anne Marie Williams, RN, BSN","twitter_card":"summary_large_image","twitter_creator":"@liveaction","twitter_site":"@liveaction","twitter_misc":{"Written by":"Anne Marie Williams, RN, BSN","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/#article","isPartOf":{"@id":"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/"},"author":{"name":"Anne Marie Williams, RN, BSN","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/48e3f680e24f898411f4ea650018e01b"},"headline":"FDA considers approval of first over-the-counter birth control pill","datePublished":"2022-11-13T19:36:05+00:00","dateModified":"2022-11-11T19:41:41+00:00","mainEntityOfPage":{"@id":"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/"},"wordCount":821,"publisher":{"@id":"https:\/\/archive.liveaction.org\/news\/#organization"},"articleSection":["Analysis","Newsbreak"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/","url":"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/","name":"FDA considers approval of first over-the-counter birth control pill","isPartOf":{"@id":"https:\/\/archive.liveaction.org\/news\/#website"},"datePublished":"2022-11-13T19:36:05+00:00","dateModified":"2022-11-11T19:41:41+00:00","description":"HRA Pharma cited 7 years of safety studies as proof of O-pill\u2019s appropriateness for OTC use, but its largest study followed 1,000 women for just 6 months.","breadcrumb":{"@id":"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/archive.liveaction.org\/news\/fda-considers-first-counter-birth-control-pill\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/archive.liveaction.org\/news\/"},{"@type":"ListItem","position":2,"name":"FDA considers approval of first over-the-counter birth control pill"}]},{"@type":"WebSite","@id":"https:\/\/archive.liveaction.org\/news\/#website","url":"https:\/\/archive.liveaction.org\/news\/","name":"Live Action News","description":"Covering Human Rights, Abortion, & Pro-Life Issues","publisher":{"@id":"https:\/\/archive.liveaction.org\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/archive.liveaction.org\/news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/archive.liveaction.org\/news\/#organization","name":"Live Action","url":"https:\/\/archive.liveaction.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png","contentUrl":"https:\/\/archive.liveaction.org\/news\/wp-content\/uploads\/2016\/06\/Live-Action-Logo-Black.png","width":701,"height":710,"caption":"Live Action"},"image":{"@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/liveaction","https:\/\/twitter.com\/liveaction","https:\/\/www.instagram.com\/liveactionorg\/","https:\/\/www.pinterest.com\/LiveActionFilms\/","https:\/\/www.youtube.com\/user\/LiveActionFilms"]},{"@type":"Person","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/48e3f680e24f898411f4ea650018e01b","name":"Anne Marie Williams, RN, BSN","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/archive.liveaction.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/27753e50a006dd85ec60e2a77e6c6a52?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/27753e50a006dd85ec60e2a77e6c6a52?s=96&d=mm&r=g","caption":"Anne Marie Williams, RN, BSN"},"description":"Anne Marie Williams is a mom of five with 10 years of nursing experience, primarily in the ICU setting. Her writing advocates for an approach to women's health that respects and supports the female body and fertility, and educates on the harms of hormonal birth control. She hosts a postpartum podcast to help other moms experience postpartum as a time of grit, growth, and grace.","url":"https:\/\/archive.liveaction.org\/news\/author\/anne-marie-williams\/"}]}},"_links":{"self":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/279593"}],"collection":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/users\/635"}],"replies":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/comments?post=279593"}],"version-history":[{"count":5,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/279593\/revisions"}],"predecessor-version":[{"id":279647,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/posts\/279593\/revisions\/279647"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/media\/279621"}],"wp:attachment":[{"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/media?parent=279593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/categories?post=279593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/archive.liveaction.org\/news\/wp-json\/wp\/v2\/tags?post=279593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}